Ruxolitinib Cream FDA Approved for Atopic Dermatitis

Press/Media

Period	24 Jan 2022

Media coverage

Title	Ruxolitinib Cream FDA Approved for Atopic Dermatitis
Media name/outlet	Drugtopics.com
Country/Territory	United States
Date	24/01/22
URL	ct.moreover.com/?a=46859517731&p=1gw&v=1&x=G7pdIf33JtCnUGVclxLzmQ
Persons	Alexandra Golant